---
date: "2021-04-10T00:00:00Z"
external_link: ""
image:
  focal_point: Smart
  preview_only: true
summary: Double-blind randomised multi-centre, placebo-controlled trial of combined ACE-inhibitor and beta-blocker therapy in males with Duchenne muscular dystrophy
tags:
- DMD Heart
title: DMD Heart
url_code: ""
url_pdf: ""
url_slides: ""
url_video: ""
---

DMD Heart was funded by a grant from the [BHF](https://www.bhf.org.uk/) to CI [John Bourke](https://www.newcastle-hospitals.nhs.uk/consultants/dr-john-p-bourke/) and team.

It was a multicentre, parallel group, randomised, placebo-controlled study of combination therapy with an ACE inhibitor (perindopril) and a beta-blocker (bisoprolol) in boys with Duchenne muscular dystrophy.

You can find out more from DMD Heart's [protocol paper](http://dx.doi.org/10.1136/bmjopen-2018-022572), from it's registration on [ISRCTN](https://doi.org/10.1186/ISRCTN50395346), of from it's [results](https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005932-10/results).
